Key facts
- This page summarizes KABAKOFF DAVID S's Form 4 filing for CASTLE BIOSCIENCES INC (CSTL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Jun 2021, 17:47.
KABAKOFF DAVID S - 17 Jun 2021 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)
- Reporting relationship
- Director
- Issuer ticker
- CSTL
- Reported as of
- 17 Jun 2021
- Net transaction value
- -$2,252,088
- SEC form
- 4
- Accepted by SEC
- 21 Jun 2021, 17:47:19 UTC
- Prior SEC filing
- 14 Jun 2021
- Next SEC filing
- 28 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Greg Acosta, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
KABAKOFF DAVID S filed Form 4 for CASTLE BIOSCIENCES INC (CSTL) on 21 Jun 2021.
Change
- Previous filing in this sequence was filed on 14 Jun 2021.
- Current net transaction value: -$2,252,088.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CSTL
transaction
Common Stock
Sale
- Transaction value
- $2,252,088
- Shares
- -30,000
- Change %
- -5.6%
- Price
- $75.07
- Shares after
- 503,577
- Date
- 17 Jun 2021
- Ownership
- By L.P.
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Sofinnova HealthQuest Partners, L.P. on December 17, 2020.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $75.0453 to $75.0922, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Footnote F3
Held by Sofinnova HealthQuest Partners, L.P., or HealthQuest Partners. HealthQuest Venture Management, L.L.C., or HealthQuest Management, is the general partner of HealthQuest Partners. David Kabakoff, Ph.D., the Reporting Person, is a partner of HealthQuest Management. Garheng Kong is the managing member of HealthQuest Management and has sole voting and investment power over the shares held by HealthQuest Partners. Each of HealthQuest Management, Mr. Kong and Dr. Kabakoff disclaims beneficial ownership over all shares held by HealthQuest Partners except to the extent of any pecuniary interest therein.